Document is current
Any future updates will be listed below
-
Authors
Kaneto, Hideaki https://orcid.org/0000-0001-7898-1943
Hatanaka, Makiko
Morimoto, Yukiko
Takahashi, Yoko https://orcid.org/0000-0003-2481-9574
Terauchi, Yasuo https://orcid.org/0000-0002-8872-3697
-
Funding
Funding for this research was provided by:
Sanofi K.K.
- License Information
-
More Information
Article History
Received: 5 November 2024
Accepted: 4 February 2025
First Online: 8 March 2025
Declarations
:
: Hideaki Kaneto has received lecture fees from Eli Lilly Japan K.K., Nippon Boehringer Ingelheim Co., Ltd., Sanofi K.K., Novo Nordisk Pharma Ltd., Sumitomo Pharma Co., Ltd., Daiichi Sankyo Company, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., MSD K.K., Astellas Pharma Inc. and AstraZeneca K.K.; research expenses or grants from Taisho Pharmaceutical Co., Ltd., Summit Pharma Co., Ltd. and Nippon Boehringer Ingelheim Co., Ltd.; scholarship (incentive) donations, etc. from Eli Lilly Japan K.K., Nippon Boehringer Ingelheim Co., Ltd., Sanofi K.K., Novo Nordisk Pharma Ltd., Sumitomo Pharma Co., Ltd., Daiichi Sankyo Company, Mitsubishi Tanabe Pharma Corporation, Kowa Company, Ltd., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., MSD K.K., Astellas Pharma Inc. and Abbott Japan LLC. Yasuo Terauchi has received lecture fees from MSD K.K., Nippon Boehringer Ingelheim Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., Eli Lilly Japan K.K., Sanofi K.K., Sumitomo Pharma Co., Ltd., AstraZeneca K.K., Astellas Pharma Inc., and Kowa Company, Ltd.; and scholarship (incentive) donations, etc. from Nippon Boehringer Ingelheim Co., Ltd. and Sumitomo Pharma Co., Ltd. Makiko Hatanaka, Yukiko Morimoto and Yoko Takahashi are employees of Sanofi K.K. Makiko Hatanaka is a shareholder of Sanofi K.K.
: The study was conducted in accordance with the Japanese Ministerial Ordinance on Good Post-Marketing Study Practice (Ministry of Health, Labour and Welfare Ordinance No. 171, December 20, 2004) and the ethical guidelines for medical and health research involving human subjects. Under these Japanese regulations, this study was conducted without the review or approval by the ethics committee of the participating medical institutions. All data were collected from the MDV database; the authors had no access to individuals’ medical records.
